News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Gianrico Farrugia: We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.
Photo from Gianrico Farrugia/LinkedIn
Aug 21, 2023, 17:03

Gianrico Farrugia: We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.

“We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.

Fortune highlights the spread of modern hospital-at-home programs in America, including Mayo’s model to provide options for patients to receive high-quality care outside of a hospital building.”
For details click here.
cancer Fortune Gianrico Farrugia LinkedIn Mayo Clinic OncoDaily Oncology
Special Coverage
Blog
Aug 2, 2025, 19:41
Michael Sapienza: Hopeful that Secretary Kennedy Will Reinforce the Tremendous Progress in Prevention Through No-Cost CRC Screenings
Blog
Aug 2, 2025, 19:31
Annabelle Gurwitch: My 5 Year Cancerversary
Blog
Aug 2, 2025, 19:14
Patrick C. Ma: Congratulations to Hyma Polimera for Her Robert A. Winn Excellence in Clinical Trials Award Program CDA
Opinion
Aug 2, 2025, 18:28
Mark Lawler: Cancer Is a No-Brainer - Isolationism in Health Research Is Brainless
Blog
Aug 2, 2025, 18:22
Ashish M. Kamat: Such an Energizing and Impactful BCANTT25
Insight
Aug 2, 2025, 18:14
Jonathan Friedberg: "A Cure, My Kingdom for a Cure" - CAR-T in Refractory Myeloma
Blog
Aug 2, 2025, 18:08
Deepa Rangachari: Training for Community-based Careers
Insight
Aug 2, 2025, 18:02
Anirban Maitra: "Anti-Medicine" Food
Insight
Aug 2, 2025, 17:54
Fred Hirsch: Still A Long Way To Go in Small Cell Lung Cancer
Blog
Aug 2, 2025, 17:50
2025 IPOS/COSA World Congress Announced Accepted Abstracts
Immune Oncology
Aug 2, 2025, 17:17
Real-World Study Confirms Nivolumab Plus Cabozantinib Improves Survival in Metastatic RCC
Science
Aug 2, 2025, 16:59
Myeloma Paper of the Day, August 2nd, Suggested by Robert Orlowski